For research and educational purposes only. Not medical advice.
CJC-1295 Reference
Educational, not medical advice reference for CJC-1295: GH Release, Longevity; regulatory status, evidence posture, source review, and schedule notes. Also k…
Reference summary
Published human data are primarily on the long-acting DAC-linked form, which increased GH and IGF-1 while preserving pulsatility in healthy men. No-DAC and DAC products are pharmacologically distinct, and long-term outcome data remain limited.
- Categories
- GH Release, Longevity
- Aliases
- CJC-1295 acetate, CJC-1295 no DAC, CJC-1295 with DAC, GHRH analog, Mod GRF 1-29
- Evidence posture
- human — Human data are mainly small DAC-form endocrine studies, not broad long-term outcome trials.
- Regulatory status
- No FDA-approved CJC-1295 drug label. FDA lists CJC-1295 among bulk substances with safety-risk concerns for compounding.
- Content review status
- research reference